Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2012-04-16

EMA Withdrawn: Livensa (testosterone) — Warner Chilcott  Deutschland GmbH

View source ↗

Summary

Withdrawn medicine Livensa (testosterone) by Warner Chilcott Deutschland GmbH; status indicates full withdrawal from market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Livensa (testosterone)

Snippet

Status: Withdrawn. Therapeutic area: Sexual Dysfunctions, Psychological. MAH: Warner Chilcott  Deutschland GmbH. Decision date: 18/07/2011